Andrew Yuen
Analyst-Equity bei Gordonmd Global Investments LP
Profil
Mr. Andrew Yuen is a Senior Analyst at Gordonmd Global Investments LP.
Prior to joining, He was an Equity Research Associate for two years at The Capital Group.
Before joining The Capital Group, He was employed by J.P.
Morgan Securities LLC.
He holds a bachelor’s degree in Business Administration, with a concentration in Finance, from the University of Washington.
Aktive Positionen von Andrew Yuen
| Unternehmen | Position | Beginn |
|---|---|---|
Gordonmd Global Investments LP
 Gordonmd Global Investments LP Investment ManagersFinance Gordonmd Global Investments LP is a private company that combines medical and investing expertise to create a singular advantage for biopharmaceutical investors. The company is based in Beverly Hills, CA. The company is dedicated to sourcing highly differentiated investments through their experience and expertise as investment professionals with distinctive backgrounds in the medical/healthcare/finance space. The company was founded in 2021 by Craig Gordon, MD, a licensed physician, who has been the CEO since 2021. | Analyst-Equity | 01.01.2021 |
Ausbildung von Andrew Yuen
| University of Washington | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Gordonmd Global Investments LP
Gordonmd Global Investments LP Investment ManagersFinance Gordonmd Global Investments LP is a private company that combines medical and investing expertise to create a singular advantage for biopharmaceutical investors. The company is based in Beverly Hills, CA. The company is dedicated to sourcing highly differentiated investments through their experience and expertise as investment professionals with distinctive backgrounds in the medical/healthcare/finance space. The company was founded in 2021 by Craig Gordon, MD, a licensed physician, who has been the CEO since 2021. | Finance |
